Cite
HARVARD Citation
Batlevi, C. et al. (2017). A phase 2 study of mocetinostat, a histone deacetylase inhibitor, in relapsed or refractory lymphoma. British journal of haematology. pp. 434-441. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Batlevi, C. et al. (2017). A phase 2 study of mocetinostat, a histone deacetylase inhibitor, in relapsed or refractory lymphoma. British journal of haematology. pp. 434-441. [Online].